ArticleProceedings of the National Academy of Sciences of the United States of America2003

Identification of Down's syndrome critical locus gene SIM2-s as a drug therapy target for solid tumors.

Maurice Phil DeYoung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.